Regulatory T-cells at the interface between human host and pathogens in infectious diseases and vaccination

Frontiers in Immunology

Volumn 6, Issue MAY, 2015, Pages

  Boer, Mardi C ^a   Joosten, Simone A ^a   Ottenhoff, Tom H M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

BCG; Human regulatory T cells; Infection; Leprosy; Pathogens; Regulatory T cells; Tuberculosis; Vaccination

Indexed keywords

BACTERIAL INFECTION; CELL ACTIVATION; CELL DIFFERENTIATION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOREGULATION; INFECTION; LEPROSY; MYCOBACTERIUM BOVIS BCG; NONHUMAN; PARASITOSIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; TUBERCULOSIS; VACCINATION; VIRUS INFECTION;

EID: 84934276060     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00217     Document Type: Review

References (177)

1. Belkaid Y, Tarbell K. Regulatory T cells in the control of host-microorganism interactions. Annu Rev Immunol (2009) 27:551-89. doi: 10.1146/annurev.immunol.021908.132723
2. Sutmuller RP, Morgan ME, Netea MG, Grauer O, Adema GJ. Toll-like receptors on regulatory T cells: expanding immune regulation. Trends Immunol (2006) 27:387-93. doi:10.1016/j.it.2006.06.005
3. Maizels RM, Smith KA. Regulatory T cells in infection. Adv Immunol (2011) 112:73-136. doi:10.1016/B978-0-12-387827-4.00003-6
4. Abbas AK, Benoist C, Bluestone JA, Campbell DJ, Ghosh S, Hori S, et al. Regulatory T cells: recommendations to simplify the nomenclature. Nat Immunol (2013) 14:307-8. doi:10.1038/ni.2554
5. Joosten SA, Ottenhoff TH. Human CD4 and CD8 regulatory T cells in infectious diseases and vaccination. Hum Immunol (2008) 69:760-70. doi:10.1016/j.humimm.2008.07.017
6. Ottenhoff TH, Elferink DG, Klatser PR, de Vries RR. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells. Nature (1986) 322:462-4. doi:10.1038/322462a0
7. Modlin RL, Kato H, Mehra V, Nelson EE, Fan XD, Rea TH, et al. Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions. Nature (1986) 322:459-61. doi:10.1038/322459a0
8. Kapp JA, Bucy RP. CD8+ suppressor T cells resurrected. Hum Immunol (2008) 69:715-20. doi:10.1016/j.humimm.2008.07.018
9. Wing JB, Sakaguchi S. Multiple treg suppressive modules and their adaptability. Front Immunol (2012) 3:178. doi:10.3389/fimmu.2012.00178
10. Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol (2008) 8:523-32. doi:10.1038/nri2343
11. Wammes LJ, Hamid F, Wiria AE, de Gier B, Sartono E, Maizels RM, et al. Regulatory T cells in human geohelminth infection suppress immune responses to BCG and Plasmodium falciparum. Eur J Immunol (2010) 40:437-42. doi:10.1002/eji.200939699
12. van Riet E, Hartgers FC, Yazdanbakhsh M. Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology (2007) 212:475-90. doi:10.1016/j.imbio.2007.03.009
13. Qureshi OS, Zheng Y, Nakamura K, Attridge K, Manzotti C, Schmidt EM, et al. Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science (2011) 332:600-3. doi:10.1126/science.1202947
14. Dwyer KM, Deaglio S, Gao W, Friedman D, Strom TB, Robson SC. CD39 and control of cellular immune responses. Purinergic Signal (2007) 3:171-80. doi:10.1007/s11302-006-9050-y
15. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol (2011) 11:723-37. doi:10.1038/nri3073
16. Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E, et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci U S A (2004) 101:4560-5. doi:10.1073/pnas.0400983101
17. Savage ND, de Boer T, Walburg KV, Joosten SA, van MK, Geluk A, et al. Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1. J Immunol (2008) 181:2220-6. doi:10.4049/jimmunol.181.3.2220
18. Gupta N, Hegde P, Lecerf M, Nain M, Kaur M, Kalia M, et al. Japanese encephalitis virus expands regulatory T cells by increasing the expression of PD-L1 on dendritic cells. Eur J Immunol (2014) 44:1363-74. doi:10.1002/eji.201343701
19. Trinath J, Maddur MS, Kaveri SV, Balaji KN, Bayry J. Mycobacterium tuberculosis promotes regulatory T-cell expansion via induction of programmed death-1 ligand 1 (PD-L1, CD274) on dendritic cells. J Infect Dis (2012) 205:694-6. doi:10.1093/infdis/jir820
20. Periasamy S, Dhiman R, Barnes PF, Paidipally P, Tvinnereim A, Bandaru A, et al. Programmed death 1 and cytokine inducible SH2-containing protein dependent expansion of regulatory T cells upon stimulation with Mycobacterium tuberculosis. J Infect Dis (2011) 203:1256-63. doi:10.1093/infdis/jir011
21. Siddiqui KF, Amir M, Gurram RK, Khan N, Arora A, Rajagopal K, et al. Latency-associated protein Acr1 impairs dendritic cell maturation and functionality: a possible mechanism of immune evasion by Mycobacterium tuberculosis. J Infect Dis (2014) 209:1436-45. doi:10.1093/infdis/jit595
22. Dubois-Colas N, Petit-Jentreau L, Barreiro LB, Durand S, Soubigou G, Lecointe C, et al. Extracellular adenosine triphosphate affects the response of human macrophages infected with Mycobacterium tuberculosis. J Infect Dis (2014) 210:824-33. doi:10.1093/infdis/jiu135
23. Ohta A, Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature (2001) 414:916-20. doi:10.1038/414916a
24. Hall CH, Kassel R, Tacke RS, Hahn YS. HCV+ hepatocytes induce human regulatory CD4+ T cells through the production of TGF-beta. PLoS One (2010) 5:e12154. doi:10.1371/journal.pone.0012154
25. Beswick EJ, Pinchuk IV, Earley RB, Schmitt DA, Reyes VE. Role of gastric epithelial cell-derived transforming growth factor beta in reduced CD4+ T cell proliferation and development of regulatory T cells during Helicobacter pylori infection. Infect Immun (2011) 79:2737-45. doi:10.1128/IAI.01146-10
26. Mertens J, Fabri M, Zingarelli A, Kubacki T, Meemboor S, Groneck L, et al. Streptococcus pneumoniae serotype 1 capsular polysaccharide induces CD8CD28 regulatory T lymphocytes by TCR crosslinking. PLoS Pathog (2009) 5:e1000596. doi:10.1371/journal.ppat.1000596
27. Grainger JR, Smith KA, Hewitson JP, McSorley HJ, Harcus Y, Filbey KJ, et al. Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-beta pathway. J Exp Med (2010) 207:2331-41. doi:10.1084/jem.20101074
28. Sharma S, Rajasagi NK, Veiga-Parga T, Rouse BT. Herpes virus entry mediator (HVEM) modulates proliferation and activation of regulatory T cells following HSV-1 infection. Microbes Infect (2014) 16:648-60. doi:10.1016/j.micinf.2014.06.005
29. Ji J, Cloyd MW. HIV-1 binding to CD4 on CD4+CD25+ regulatory T cells enhances their suppressive function and induces them to home to, and accumulate in, peripheral and mucosal lymphoid tissues: an additional mechanism of immunosuppression. Int Immunol (2009) 21:283-94. doi:10.1093/intimm/dxn146
30. Harding CV, Boom WH. Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors. Nat Rev Microbiol (2010) 8:296-307. doi:10.1038/nrmicro2321
31. Saraav I, Singh S, Sharma S. Outcome of Mycobacterium tuberculosis and toll-like receptor interaction: immune response or immune evasion? Immunol Cell Biol (2014) 92:741-6. doi:10.1038/icb.2014.52
32. McBride A, Konowich J, Salgame P. Host defense and recruitment of Foxp3(+) T regulatory cells to the lungs in chronic Mycobacterium tuberculosis infection requires toll-like receptor 2. PLoS Pathog (2013) 9:e1003397. doi:10.1371/journal.ppat.1003397
33. Hisaeda H, Tetsutani K, Imai T, Moriya C, Tu L, Hamano S, et al. Malaria parasites require TLR9 signaling for immune evasion by activating regulatory T cells. J Immunol (2008) 180:2496-503. doi:10.4049/jimmunol.180.4.2496
34. O'Neill LA, Hardie DG. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature (2013) 493:346-55. doi:10.1038/nature11862
35. Schiering C, Krausgruber T, Chomka A, Frohlich A, Adelmann K, Wohlfert EA, et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature (2014) 513:564-8. doi:10.1038/nature13577
36. Arpaia N, Campbell C, Fan X, Dikiy S, van der V, deRoos P, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature (2013) 504:451-5. doi:10.1038/nature12726
37. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature (2013) 504:446-50. doi:10.1038/nature12721
38. Veiga-Parga T, Sehrawat S, Rouse BT. Role of regulatory T cells during virus infection. Immunol Rev (2013) 255:182-96. doi:10.1111/imr.12085
39. Manangeeswaran M, Jacques J, Tami C, Konduru K, Amharref N, Perrella O, et al. Binding of hepatitis A virus to its cellular receptor 1 inhibits T-regulatory cell functions in humans. Gastroenterology (2012) 142:1516-25. doi:10.1053/j.gastro.2012.02.039
40. Luhn K, Simmons CP, Moran E, Dung NT, Chau TN, Quyen NT, et al. Increased frequencies of CD4+ CD25(high) regulatory T cells in acute dengue infection. J Exp Med (2007) 204:979-85. doi:10.1084/jem.20061381
41. Lund JM, Hsing L, Pham TT, Rudensky AY. Coordination of early protective immunity to viral infection by regulatory T cells. Science (2008) 320:1220-4. doi:10.1126/science.1155209
42. Kassiotis G, O'Garra A. Immunology. Immunity benefits from a little suppression. Science (2008) 320:1168-9. doi:10.1126/science.1159090
43. Moreno-Fernandez ME, Rueda CM, Rusie LK, Chougnet CA. Regulatory T cells control HIV replication in activated T cells through a cAMP-dependent mechanism. Blood (2011) 117:5372-80. doi:10.1182/blood-2010-12-323162
44. Haase AT. Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol (2005) 5:783-92. doi:10.1038/nri1706
45. Graham JB, Da CA, Lund JM. Regulatory T cells shape the resident memory T cell response to virus infection in the tissues. J Immunol (2014) 192:683-90. doi:10.4049/jimmunol.1202153
46. Aalaei-Andabili SH, Alavian SM. Regulatory T cells are the most important determinant factor of hepatitis B infection prognosis: a systematic review and meta-analysis. Vaccine (2012) 30:5595-602. doi:10.1016/j.vaccine.2012.06.063
47. Losikoff PT, Self AA, Gregory SH. Dendritic cells, regulatory T cells and the pathogenesis of chronic hepatitis C. Virulence (2012) 3:610-20. doi:10.4161/viru.21823
48. Self AA, Losikoff PT, Gregory SH. Divergent contributions of regulatory T cells to the pathogenesis of chronic hepatitis C. Hum Vaccin Immunother (2013) 9:1569-76. doi:10.4161/hv.24726
49. Riezu-Boj JI, Larrea E, Aldabe R, Guembe L, Casares N, Galeano E, et al. Hepatitis C virus induces the expression of CCL17 and CCL22 chemokines that attract regulatory T cells to the site of infection. J Hepatol (2011) 54:422-31. doi:10.1016/j.jhep.2010.07.014
50. Chevalier MF, Weiss L. The split personality of regulatory T cells in HIV infection. Blood (2013) 121:29-37. doi:10.1182/blood-2012-07-409755
51. Moreno-Fernandez ME, Joedicke JJ, Chougnet CA. Regulatory T cells diminish HIV infection in dendritic cells-conventional CD4(+) T cell clusters. Front Immunol (2014) 5:199. doi:10.3389/fimmu.2014.00199
52. Nikolova M, Carriere M, Jenabian MA, Limou S, Younas M, Kok A, et al. CD39/adenosine pathway is involved in AIDS progression. PLoS Pathog (2011) 7:e1002110. doi:10.1371/journal.ppat.1002110
53. Schulze Zur WJ, Thomssen A, Hartjen P, Toth I, Lehmann C, Meyer-Olson D, et al. Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease. J Virol (2011) 85:1287-97. doi:10.1128/JVI.01758-10
54. Johanns TM, Ertelt JM, Rowe JH, Way SS. Regulatory T cell suppressive potency dictates the balance between bacterial proliferation and clearance during persistent Salmonella infection. PLoS Pathog (2010) 6:e1001043. doi:10.1371/journal.ppat.1001043
55. Monack DM. Helicobacter and Salmonella persistent infection strategies. Cold Spring Harb Perspect Med (2013) 3:a010348. doi:10.1101/cshperspect.a010348
56. Neill DR, Coward WR, Gritzfeld JF, Richards L, Garcia-Garcia FJ, Dotor J, et al. Density and duration of pneumococcal carriage is maintained by transforming growth factor beta1 and T regulatory cells. Am J Respir Crit Care Med (2014) 189:1250-9. doi:10.1164/rccm.201401-0128OC
57. Cook KW, Letley DP, Ingram RJ, Staples E, Skjoldmose H, Atherton JC, et al. CCL20/CCR6-mediated migration of regulatory T cells to the Helicobacter pylori-infected human gastric mucosa. Gut (2014) 63:1550-9. doi:10.1136/gutjnl-2013-306253
58. Lina TT, Alzahrani S, Gonzalez J, Pinchuk IV, Beswick EJ, Reyes VE. Immune evasion strategies used by Helicobacter pylori. World J Gastroenterol (2014) 20:12753-66. doi:10.3748/wjg.v20.i36.12753
59. Round JL, Mazmanian SK. Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A (2010) 107:12204-9. doi:10.1073/pnas.0909122107
60. Santos RC, Gomes-Santos AC, Garcias MT, de AM, Diniz LT, Mariadassou M, et al. Local and systemic immune mechanisms underlying the anti-colitis effects of the dairy bacterium Lactobacillus delbrueckii. PLoS One (2014) 9:e85923. doi:10.1371/journal.pone.0085923
61. Nakamizo S, Egawa G, Honda T, Nakajima S, Belkaid Y, Kabashima K. Commensal bacteria and cutaneous immunity. Semin Immunopathol (2014) 37:73-80. doi:10.1007/s00281-014-0452-6
62. Marsland BJ, Gollwitzer ES. Host-microorganism interactions in lung diseases. Nat Rev Immunol (2014) 14:827-35. doi:10.1038/nri3769
63. Suffia IJ, Reckling SK, Piccirillo CA, Goldszmid RS, Belkaid Y. Infected site-restricted Foxp3+ natural regulatory T cells are specific for microbial antigens. J Exp Med (2006) 203:777-88. doi:10.1084/jem.20052056
64. Suffia I, Reckling SK, Salay G, Belkaid Y. A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection. J Immunol (2005) 174:5444-55. doi:10.4049/jimmunol.174.9.5444
65. Mendez S, Reckling SK, Piccirillo CA, Sacks D, Belkaid Y. Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J Exp Med (2004) 200:201-10. doi:10.1084/jem.20040298
66. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature (2002) 420:502-7. doi:10.1038/nature01152
67. Nagase H, Jones KM, Anderson CF, Noben-Trauth N. Despite increased CD4+Foxp3+ cells within the infection site, BALB/c IL-4 receptor-deficient mice reveal CD4+Foxp3-negative T cells as a source of IL-10 in Leishmania major susceptibility. J Immunol (2007) 179:2435-44. doi:10.4049/jimmunol.179.4.2435
68. Campanelli AP, Roselino AM, Cavassani KA, Pereira MS, Mortara RA, Brodskyn CI, et al. CD4+CD25+ T cells in skin lesions of patients with cutaneous leishmaniasis exhibit phenotypic and functional characteristics of natural regulatory T cells. J Infect Dis (2006) 193:1313-22. doi:10.1086/502980
69. Hoseini SG, Javanmard SH, Zarkesh SH, Khamesipour A, Rafiei L, Karbalaie K, et al. Regulatory T-cell profile in early and late lesions of cutaneous leishmaniasis due to Leishmania major. J Res Med Sci (2012) 17:513-8.
70. Bourreau E, Ronet C, Darcissac E, Lise MC, Sainte MD, Clity E, et al. Intralesional regulatory T-cell suppressive function during human acute and chronic cutaneous leishmaniasis due to Leishmania guyanensis. Infect Immun (2009) 77:1465-74. doi:10.1128/IAI.01398-08
71. Bourreau E, Ronet C, Darsissac E, Lise MC, Marie DS, Clity E, et al. In leishmaniasis due to Leishmania guyanensis infection, distinct intralesional interleukin-10 and Foxp3 mRNA expression are associated with unresponsiveness to treatment. J Infect Dis (2009) 199:576-9. doi:10.1086/596508
72. Hansen DS, Schofield L. Natural regulatory T cells in malaria: host or parasite allies? PLoS Pathog (2010) 6:e1000771. doi:10.1371/journal.ppat.1000771
73. Minigo G, Woodberry T, Piera KA, Salwati E, Tjitra E, Kenangalem E, et al. Parasite-dependent expansion of TNF receptor II-positive regulatory T cells with enhanced suppressive activity in adults with severe malaria. PLoS Pathog (2009) 5:e1000402. doi:10.1371/journal.ppat.1000402
74. Torcia MG, Santarlasci V, Cosmi L, Clemente A, Maggi L, Mangano VD, et al. Functional deficit of T regulatory cells in Fulani, an ethnic group with low susceptibility to Plasmodium falciparum malaria. Proc Natl Acad Sci U S A (2008) 105:646-51. doi:10.1073/pnas.0709969105
75. Todryk SM, Bejon P, Mwangi T, Plebanski M, Urban B, Marsh K, et al. Correlation of memory T cell responses against TRAP with protection from clinical malaria, and CD4 CD25 high T cells with susceptibility in Kenyans. PLoS One (2008) 3:e2027. doi:10.1371/journal.pone.0002027
76. Weinstock JV, Elliott DE. Helminth infections decrease host susceptibility to immune-mediated diseases. J Immunol (2014) 193:3239-47. doi:10.4049/jimmunol.1400927
77. Sawant DV, Gravano DM, Vogel P, Giacomin P, Artis D, Vignali DA. Regulatory T cells limit induction of protective immunity and promote immune pathology following intestinal helminth infection. J Immunol (2014) 192:2904-12. doi:10.4049/jimmunol.1202502
78. George PJ, Anuradha R, Kumaran PP, Chandrasekaran V, Nutman TB, Babu S. Modulation of mycobacterial-specific Th1 and Th17 cells in latent tuberculosis by coincident hookworm infection. J Immunol (2013) 190:5161-8. doi:10.4049/jimmunol.1203311
79. Babu S, Bhat SQ, Kumar NP, Jayantasri S, Rukmani S, Kumaran P, et al. Human type 1 and 17 responses in latent tuberculosis are modulated by coincident filarial infection through cytotoxic T lymphocyte antigen-4 and programmed death-1. J Infect Dis (2009) 200:288-98. doi:10.1086/599797
80. Abate E, Elias D, Getachew A, Alemu S, Diro E, Britton S, et al. Effects of albendazole on the clinical outcome and immunological responses in helminth co-infected tuberculosis patients: a double blind randomized clinical trial. Int J Parasitol (2014) 45(2-3):133-40. doi:10.1016/j.ijpara.2014.09.006
81. World Health Organization. Report of the global forum on elimination of leprosy as a public health problem. World Health Organization, Geneva, Switzerland. (2006).
82. Bobosha K, Wilson L, van Meijgaarden KE, Bekele Y, Zewdie M, Van Der Ploeg-Van Schip JJ, et al. T-cell regulation in lepromatous leprosy. PLoS Negl Trop Dis (2014) 8:e2773. doi:10.1371/journal.pntd.0002773
83. Fernandes C, Goncalves HS, Cabral PB, Pinto HC, Pinto MI, Camara LM. Increased frequency of CD4 and CD8 regulatory T cells in individuals under 15 years with multibacillary leprosy. PLoS One (2013) 8:e79072. doi:10.1371/journal.pone.0079072
84. Palermo ML, Pagliari C, Trindade MA, Yamashitafuji TM, Duarte AJ, Cacere CR, et al. Increased expression of regulatory T cells and down-regulatory molecules in lepromatous leprosy. Am J Trop Med Hyg (2012) 86:878-83. doi:10.4269/ajtmh.2012.12-0088
85. Saini C, Ramesh V, Nath I. Increase in TGF-beta secreting CD4(+)CD25(+) FOXP3(+) T regulatory cells in anergic lepromatous leprosy patients. PLoS Negl Trop Dis (2014) 8:e2639. doi:10.1371/journal.pntd.0002639
86. Kumar S, Naqvi RA, Ali R, Rani R, Khanna N, Rao DN. CD4+CD25+ T regs with acetylated FoxP3 are associated with immune suppression in human leprosy. Mol Immunol (2013) 56:513-20. doi:10.1016/j.molimm.2013.04.015
87. Callegaro-Filho D, Shrestha N, Burdick AE, Haslett PA. A potential role for complement in immune evasion by Mycobacterium leprae. J Drugs Dermatol (2010) 9:1373-82.
88. Kraaij MD, Savage ND, van der Kooij SW, Koekkoek K, Wang J, van den Berg JM, et al. Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. Proc Natl Acad Sci U S A (2010) 107:17686-91. doi:10.1073/pnas.1012016107
89. Moura DF, de Mattos KA, Amadeu TP, Andrade PR, Sales JS, Schmitz V, et al. CD163 favors Mycobacterium leprae survival and persistence by promoting anti-inflammatory pathways in lepromatous macrophages. Eur J Immunol (2012) 42:2925-36. doi:10.1002/eji.201142198
90. Kumar S, Naqvi RA, Ali R, Rani R, Khanna N, Rao DN. FoxP3 provides competitive fitness to CD4(+)CD25(+) T cells in leprosy patients via transcriptional regulation. Eur J Immunol (2014) 44:431-9. doi:10.1002/eji.201343649
91. Kumar S, Naqvi RA, Khanna N, Pathak P, Rao DN. Th3 immune responses in the progression of leprosy via molecular cross-talks of TGF-beta, CTLA-4 and Cbl-b. Clin Immunol (2011) 141:133-42. doi:10.1016/j.clim.2011.06.007
92. Paolino M, Thien CB, Gruber T, Hinterleitner R, Baier G, Langdon WY, et al. Essential role of E3 ubiquitin ligase activity in Cbl-b-regulated T cell functions. J Immunol (2011) 186:2138-47. doi:10.4049/jimmunol.1003390
93. Abbas AK. A network of regulatory pathways in lepromatous leprosy. Clin Immunol (2011) 141:127. doi:10.1016/j.clim.2011.08.007
94. Shafiani S, Tucker-Heard G, Kariyone A, Takatsu K, Urdahl KB. Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J Exp Med (2010) 207:1409-20. doi:10.1084/jem.20091885
95. Scott-Browne JP, Shafiani S, Tucker-Heard G, Ishida-Tsubota K, Fontenot JD, Rudensky AY, et al. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J Exp Med (2007) 204:2159-69. doi:10.1084/jem.20062105
96. Kursar M, Koch M, Mittrucker HW, Nouailles G, Bonhagen K, Kamradt T, et al. Cutting edge: regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J Immunol (2007) 178:2661-5. doi:10.4049/jimmunol.178.5.2661
97. Shafiani S, Dinh C, Ertelt JM, Moguche AO, Siddiqui I, Smigiel KS, et al. Pathogen-specific Treg cells expand early during Mycobacterium tuberculosis infection but are later eliminated in response to interleukin-12. Immunity (2013) 38:1261-70. doi:10.1016/j.immuni.2013.06.003
98. Ottenhoff TH. New pathways of protective and pathological host defense to mycobacteria. Trends Microbiol (2012) 20(9):419-28. doi:10.1016/j.tim.2012.06.002
99. Cooper AM. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol (2009) 27:393-422. doi:10.1146/annurev.immunol.021908.132703
100. Ozeki Y, Sugawara I, Udagawa T, Aoki T, Osada-Oka M, Tateishi Y, et al. Transient role of CD4+CD25+ regulatory T cells in mycobacterial infection in mice. Int Immunol (2010) 22:179-89. doi:10.1093/intimm/dxp126
101. Chen CY, Huang D, Yao S, Halliday L, Zeng G, Wang RC, et al. IL-2 simultaneously expands Foxp3+ T regulatory and T effector cells and confers resistance to severe tuberculosis (TB): implicative Treg-T effector cooperation in immunity to TB. J Immunol (2012) 188:4278-88. doi:10.4049/jimmunol.1101291
102. Gratz IK, Campbell DJ. Organ-specific and memory treg cells: specificity, development, function, and maintenance. Front Immunol (2014) 5:333. doi:10.3389/fimmu.2014.00333
103. Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A. Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med (2006) 173:803-10. doi:10.1164/rccm.200508-1294OC
104. Ribeiro-Rodrigues R, Resende CT, Rojas R, Toossi Z, Dietze R, Boom WH, et al. A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis. Clin Exp Immunol (2006) 144:25-34. doi:10.1111/j.1365-2249.2006.03027.x
105. Chiacchio T, Casetti R, Butera O, Vanini V, Carrara S, Girardi E, et al. Characterization of regulatory T cells identified as CD4(+)CD25(high)CD39(+) in patients with active tuberculosis. Clin Exp Immunol (2009) 156:463-70. doi:10.1111/j.1365-2249.2009.03908.x
106. Singh A, Dey AB, Mohan A, Sharma PK, Mitra DK. Foxp3+ regulatory T cells among tuberculosis patients: impact on prognosis and restoration of antigen specific IFN-gamma producing T cells. PLoS One (2012) 7:e44728. doi:10.1371/journal.pone.0044728
107. Semple PL, Binder AB, Davids M, Maredza A, van Zyl-Smit RN, Dheda K. Regulatory T cells attenuate mycobacterial stasis in alveolar and blood-derived macrophages from patients with tuberculosis. Am J Respir Crit Care Med (2013) 187:1249-58. doi:10.1164/rccm.201210-1934OC
108. Burl S, Hill PC, Jeffries DJ, Holland MJ, Fox A, Lugos MD, et al. FOXP3 gene expression in a tuberculosis case contact study. Clin Exp Immunol (2007) 149:117-22. doi:10.1111/j.1365-2249.2007.03399.x
109. Joosten SA, van Meijgaarden KE, Savage ND, de Boer T, Triebel F, van der Wal A, et al. Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4. Proc Natl Acad Sci U S A (2007) 104:8029-34. doi:10.1073/pnas.0702257104
110. Joosten SA, van Meijgaarden KE, van Weeren PC, Kazi F, Geluk A, Savage ND, et al. Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity. PLoS Pathog (2010) 6:e1000782. doi:10.1371/journal.ppat.1000782
111. Meijgaarden KE, Haks MC, Caccamo N, Dieli F, Ottenhoff TH, Joosten SA. Human CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset. PLoS Pathog (2015) 11(3):e1004671. doi:10.1371/journal.ppat.1004671
112. Lim HJ, Park JS, Cho YJ, Yoon HI, Park KU, Lee CT, et al. CD4(+)FoxP3(+) T regulatory cells in drug-susceptible and multidrug-resistant tuberculosis. Tuberculosis (Edinb) (2013) 93:523-8. doi:10.1016/j.tube.2013.06.001
113. Pinheiro RO, de Oliveira EB, Dos SG, Sperandio da Silva GM, de Andrade Silva BJ, Teles RM, et al. Different immunosuppressive mechanisms in multi-drug-resistant tuberculosis and non-tuberculous mycobacteria patients. Clin Exp Immunol (2013) 171:210-9. doi:10.1111/cei.12007
114. Marin ND, Paris SC, Velez VM, Rojas CA, Rojas M, Garcia LF. Regulatory T cell frequency and modulation of IFN-gamma and IL-17 in active and latent tuberculosis. Tuberculosis (Edinb) (2010) 90:252-61. doi:10.1016/j.tube.2010.05.003
115. Kim K, Perera R, Tan DB, Fernandez S, Seddiki N, Waring J, et al. Circulating mycobacterial-reactive CD4+ T cells with an immunosuppressive phenotype are higher in active tuberculosis than latent tuberculosis infection. Tuberculosis (Edinb) (2014) 94:494-501. doi:10.1016/j.tube.2014.07.002
116. Place S, Verscheure V, de San N, Hougardy JM, Schepers K, Dirix V, et al. Heparin-binding, hemagglutinin-specific IFN-gamma synthesis at the site of infection during active tuberculosis in humans. Am J Respir Crit Care Med (2010) 182:848-54. doi:10.1164/rccm.201001-0083OC
117. Rozot V, Vigano S, Mazza-Stalder J, Idrizi E, Day CL, Perreau M, et al. Mycobacterium tuberculosis-specific CD8+ T cells are functionally and phenotypically different between latent infection and active disease. Eur J Immunol (2013) 43:1568-77. doi:10.1002/eji.201243262
118. Lewinsohn DA, Heinzel AS, Gardner JM, Zhu L, Alderson MR, Lewinsohn DM. Mycobacterium tuberculosis-specific CD8+ T cells preferentially recognize heavily infected cells. Am J Respir Crit Care Med (2003) 168:1346-52. doi:10.1164/rccm.200306-837OC
119. Silva BD, Trentini MM, da Costa AC, Kipnis A, Junqueira-Kipnis AP. Different phenotypes of CD8+ T cells associated with bacterial load in active tuberculosis. Immunol Lett (2014) 160:23-32. doi:10.1016/j.imlet.2014.03.009
120. Cyktor JC, Carruthers B, Beamer GL, Turner J. Clonal expansions of CD8+ T cells with IL-10 secreting capacity occur during chronic Mycobacterium tuberculosis infection. PLoS One (2013) 8:e58612. doi:10.1371/journal.pone.0058612
121. Garcia Jacobo RE, Serrano CJ, Enciso Moreno JA, Gaspar RO, Trujillo Ochoa JL, Uresti Rivera EE, et al. Analysis of Th1, Th17 and regulatory T cells in tuberculosis case contacts. Cell Immunol (2014) 289:167-73. doi:10.1016/j.cellimm.2014.03.010
122. Hopewell PC. Clinical Features of Tuberculosis. In: Kaufmann SH, van Helden P, editors. Handbook of Tuberculosis: Clinics, Diagnostics, Therapy and Epidemiology. Weinheim: Wiley-VCH Verlag GmbH & Co (2008). p. 89-114.
123. Sharma PK, Saha PK, Singh A, Sharma SK, Ghosh B, Mitra DK. FoxP3+ regulatory T cells suppress effector T-cell function at pathologic site in miliary tuberculosis. Am J Respir Crit Care Med (2009) 179:1061-70. doi:10.1164/rccm.200804-529OC
124. de Almeida AS, Fiske CT, Sterling TR, Kalams SA. Increased frequency of regulatory T cells and T lymphocyte activation in persons with previously treated extrapulmonary tuberculosis. Clin Vaccine Immunol (2012) 19:45-52. doi:10.1128/CVI.05263-11
125. Wu C, Zhou Q, Qin XJ, Qin SM, Shi HZ. CCL22 is involved in the recruitment of CD4+CD25 high T cells into tuberculous pleural effusions. Respirology (2010) 15:522-9. doi:10.1111/j.1440-1843.2010.01719.x
126. Geffner L, Basile JI, Yokobori N, Sabio YG, Musella R, Castagnino J, et al. CD4(+) CD25(high) forkhead box protein 3(+) regulatory T lymphocytes suppress interferon-gamma and CD107 expression in CD4(+) and CD8(+) T cells from tuberculous pleural effusions. Clin Exp Immunol (2014) 175:235-45. doi:10.1111/cei.12227
127. Ye ZJ, Zhou Q, Du RH, Li X, Huang B, Shi HZ. Imbalance of Th17 cells and regulatory T cells in tuberculous pleural effusion. Clin Vaccine Immunol (2011) 18:1608-15. doi:10.1128/CVI.05214-11
128. Yuan ML, Tong ZH, Jin XG, Zhang JC, Wang XJ, Ma WL, et al. Regulation of CD4(+) T cells by pleural mesothelial cells via adhesion molecule-dependent mechanisms in tuberculous pleurisy. PLoS One (2013) 8:e74624. doi:10.1371/journal.pone.0074624
129. Rahman S, Gudetta B, Fink J, Granath A, Ashenafi S, Aseffa A, et al. Compartmentalization of immune responses in human tuberculosis: few CD8+ effector T cells but elevated levels of FoxP3+ regulatory t cells in the granulomatous lesions. Am J Pathol (2009) 174:2211-24. doi:10.2353/ajpath.2009.080941
130. Saenz B, Hernandez-Pando R, Fragoso G, Bottasso O, Cardenas G. The dual face of central nervous system tuberculosis: a new Janus Bifrons? Tuberculosis (Edinb) (2013) 93:130-5. doi:10.1016/j.tube.2012.11.011
131. Tan DB, Yong YK, Tan HY, Kamarulzaman A, Tan LH, Lim A, et al. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis. HIV Med (2008) 9:307-16. doi:10.1111/j.1468-1293.2008.00565.x
132. Zaidi I, Peterson K, Jeffries D, Whittle H, de ST, Rowland-Jones S, et al. Immune reconstitution inflammatory syndrome and the influence of T regulatory cells: a cohort study in the Gambia. PLoS One (2012) 7:e39213. doi:10.1371/journal.pone.0039213
133. Haddow LJ, Dibben O, Moosa MY, Borrow P, Easterbrook PJ. Circulating inflammatory biomarkers can predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome. AIDS (2011) 25:1163-74. doi:10.1097/QAD.0b013e3283477d67
134. Seddiki N, Sasson SC, Santner-Nanan B, Munier M, van BD, Ip S, et al. Proliferation of weakly suppressive regulatory CD4+ T cells is associated with over-active CD4+ T-cell responses in HIV-positive patients with mycobacterial immune restoration disease. Eur J Immunol (2009) 39:391-403. doi:10.1002/eji.200838630
135. Boussiotis VA, Tsai EY, Yunis EJ, Thim S, Delgado JC, Dascher CC, et al. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest (2000) 105:1317-25. doi:10.1172/JCI9918
136. Delgado JC, Tsai EY, Thim S, Baena A, Boussiotis VA, Reynes JM, et al. Antigen-specific and persistent tuberculin anergy in a cohort of pulmonary tuberculosis patients from rural Cambodia. Proc Natl Acad Sci U S A (2002) 99:7576-81. doi:10.1073/pnas.062056099
137. Ranjbar S, Ly N, Thim S, Reynes JM, Goldfeld AE. Mycobacterium tuberculosis recall antigens suppress HIV-1 replication in anergic donor cells via CD8+ T cell expansion and increased IL-10 levels. J Immunol (2004) 172:1953-9. doi:10.4049/jimmunol.172.3.1953
138. Hougardy JM, Place S, Hildebrand M, Drowart A, Debrie AS, Locht C, et al. Regulatory T cells depress immune responses to protective antigens in active tuberculosis. Am J Respir Crit Care Med (2007) 176:409-16. doi:10.1164/rccm.200701-084OC
139. de Cassan SC, Pathan AA, Sander CR, Minassian A, Rowland R, Hill AV, et al. Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG-immunized adults vaccinated with a new tuberculosis vaccine, MVA85A. Clin Vaccine Immunol (2010) 17:1066-73. doi:10.1128/CVI.00047-10
140. Griffiths KL, Pathan AA, Minassian AM, Sander CR, Beveridge NE, Hill AV, et al. Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A. PLoS One (2011) 6:e23463. doi:10.1371/journal.pone.0023463
141. Pinheiro MB, Antonelli LR, Sathler-Avelar R, Vitelli-Avelar DM, Spindola-de-Miranda S, Guimaraes TM, et al. CD4-CD8-alphabeta and gammadelta T cells display inflammatory and regulatory potentials during human tuberculosis. PLoS One (2012) 7:e50923. doi:10.1371/journal.pone.0050923
142. Jackson-Sillah D, Cliff JM, Mensah GI, Dickson E, Sowah S, Tetteh JK, et al. Recombinant ESAT-6-CFP10 fusion protein induction of Th1/Th2 cytokines and FoxP3 expressing Treg cells in pulmonary TB. PLoS One (2013) 8:e68121. doi:10.1371/journal.pone.0068121
143. He XY, Xiao L, Chen HB, Hao J, Li J, Wang YJ, et al. T regulatory cells and Th1/Th2 cytokines in peripheral blood from tuberculosis patients. Eur J Clin Microbiol Infect Dis (2010) 29:643-50. doi:10.1007/s10096-010-0908-0
144. Feruglio SL, Tonby K, Kvale D, Dyrhol-Riise AM. Early dynamics of T helper cell cytokines and T regulatory cells in response to treatment of active Mycobacterium tuberculosis infection. Clin Exp Immunol (2014) 179(3):454-65. doi:10.1111/cei.12468
145. Sprengers D, Stoop JN, Binda RS, Kusters JG, Haagmans BL, Carotenuto P, et al. Induction of regulatory T-cells and interleukin-10-producing cells in non-responders to pegylated interferon-alpha therapy for chronic hepatitis B. Antivir Ther (2007) 12:1087-96.
146. Ndure J, Flanagan KL. Targeting regulatory T cells to improve vaccine immunogenicity in early life. Front Microbiol (2014) 5:477. doi:10.3389/fmicb.2014.00477
147. Ha TY, Waksman BH, Treffers HP. The thymic suppressor cell. I. Separation of subpopulations with suppressor activity. J Exp Med (1974) 139:13-23. doi:10.1084/jem.139.1.13
148. Marchant A, Goetghebuer T, Ota MO, Wolfe I, Ceesay SJ, de Groote D, et al. Newborns develop a Th1-type immune response to Mycobacterium bovis Bacillus Calmette-Guerin vaccination. J Immunol (1999) 163:2249-55.
149. Hussey GD, Watkins ML, Goddard EA, Gottschalk S, Hughes EJ, Iloni K, et al. Neonatal mycobacterial specific cytotoxic T-lymphocyte and cytokine profiles in response to distinct BCG vaccination strategies. Immunology (2002) 105:314-24. doi:10.1046/j.1365-2567.2002.01366.x
150. Kaufmann SH. Tuberculosis vaccines: time to think about the next generation. Semin Immunol (2013) 25:172-81. doi:10.1016/j.smim.2013.04.006
151. Hanekom WA. The immune response to BCG vaccination of newborns. Ann N Y Acad Sci (2005) 1062:69-78. doi:10.1196/annals.1358.010
152. Akkoc T, Aydogan M, Yildiz A, Karakoc-Aydiner E, Eifan A, Keles S, et al. Neonatal BCG vaccination induces IL-10 production by CD4+ CD25+ T cells. Pediatr Allergy Immunol (2010) 21:1059-63. doi:10.1111/j.1399-3038.2010.01051.x
153. Li L, Qiao D, Zhang X, Liu Z, Wu C. The immune responses of central and effector memory BCG-specific CD4+ T cells in BCG-vaccinated PPD+ donors were modulated by Treg cells. Immunobiology (2011) 216:477-84. doi:10.1016/j.imbio.2010.09.003
154. Boer MC, van Meijgaarden KE, Joosten SA, Ottenhoff TH. CD8+ regulatory T cells, and not CD4+ T cells, dominate suppressive phenotype and function after in vitro live Mycobacterium bovis-BCG activation of human cells. PLoS One (2014) 9:e94192. doi:10.1371/journal.pone.0094192
155. Boer MC, van Meijgaarden KE, Bastid J, Ottenhoff TH, Joosten SA. CD39 is involved in mediating suppression by Mycobacterium bovis BCG-activated human CD8(+) CD39(+) regulatory T cells. Eur J Immunol (2013) 43:1925-32. doi:10.1002/eji.201243286
156. Day CL, Tameris M, Mansoor N, van RM, de KM, Geldenhuys H, et al. Induction and regulation of T-cell immunity by the novel tuberculosis vaccine M72/AS01 in South African adults. Am J Respir Crit Care Med (2013) 188:492-502. doi:10.1164/rccm.201208-1385OC
157. Matsumiya M, Stylianou E, Griffiths K, Lang Z, Meyer J, Harris SA, et al. Roles for Treg expansion and HMGB1 signaling through the TLR1-2-6 axis in determining the magnitude of the antigen-specific immune response to MVA85A. PLoS One (2013) 8:e67922. doi:10.1371/journal.pone.0067922
158. Matsumiya M, Harris SA, Satti I, Stockdale L, Tanner R, O'Shea MK, et al. Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response. BMC Infect Dis (2014) 14:314. doi:10.1186/1471-2334-14-314
159. Andersen P, Doherty TM. The success and failure of BCG-implications for a novel tuberculosis vaccine. Nat Rev Microbiol (2005) 3:656-62. doi:10.1038/nrmicro1211
160. Coleman MM, Keane J, Mills KH. Editorial: Tregs and BCG-dangerous liaisons in TB. J Leukoc Biol (2010) 88:1067-9. doi:10.1189/jlb.0710419
161. Ho P, Wei X, Seah GT. Regulatory T cells induced by Mycobacterium chelonae sensitization influence murine responses to bacille Calmette-Guerin. J Leukoc Biol (2010) 88:1073-80. doi:10.1189/jlb.0809582
162. Beverley P, Ronan E, Lee L, Arnold I, Bolinger B, Powrie F, et al. Environmental effects on protection against Mycobacterium tuberculosis after immunization with Ad85A. Vaccine (2013) 31:1086-93. doi:10.1016/j.vaccine.2012.12.024
163. Perry S, Hussain R, Parsonnet J. The impact of mucosal infections on acquisition and progression of tuberculosis. Mucosal Immunol (2011) 4:246-51. doi:10.1038/mi.2011.11
164. Elias D, Britton S, Aseffa A, Engers H, Akuffo H. Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production. Vaccine (2008) 26:3897-902. doi:10.1016/j.vaccine.2008.04.083
165. Lacan G, Dang H, Middleton B, Horwitz MA, Tian J, Melega WP, et al. Bacillus Calmette-Guerin vaccine-mediated neuroprotection is associated with regulatory T-cell induction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease. J Neurosci Res (2013) 91:1292-302. doi:10.1002/jnr.23253
166. Lee J, Reinke EK, Zozulya AL, Sandor M, Fabry Z. Mycobacterium bovis bacille Calmette-Guerin infection in the CNS suppresses experimental autoimmune encephalomyelitis and Th17 responses in an IFN-gamma-independent manner. J Immunol (2008) 181:6201-12. doi:10.4049/jimmunol.181.9.6201
167. Kim YJ, Kim HJ, Kang MJ, Yu HS, Seo JH, Kim HY, et al. Bacillus Calmette-Guerin suppresses asthmatic responses via CD4(+)CD25(+) regulatory T cells and dendritic cells. Allergy Asthma Immunol Res (2014) 6:201-7. doi:10.4168/aair.2014.6.3.201
168. Lagranderie M, Kluge C, Kiefer-Biasizzo H, Abolhassani M, Nahori MA, Fitting C, et al. Mycobacterium bovis Bacillus Calmette-Guerin killed by extended freeze-drying reduces colitis in mice. Gastroenterology (2011) 141(642-52):652. doi:10.1053/j.gastro.2011.05.002
169. Andrieu JM, Chen S, Lai C, Guo W, Lu W. Mucosal SIV vaccines comprising inactivated virus particles and bacterial adjuvants induce CD8(+) T-regulatory cells that suppress SIV-positive CD4(+) T-cell activation and prevent SIV infection in the macaque model. Front Immunol (2014) 5:297. doi:10.3389/fimmu.2014.00297
170. Bhattacharya D, Dwivedi VP, Maiga M, Maiga M, Van KL, Bishai WR, et al. Small molecule-directed immunotherapy against recurrent infection by Mycobacterium tuberculosis. J Biol Chem (2014) 289:16508-15. doi:10.1074/jbc. M114.558098
171. Bhattacharya D, Dwivedi VP, Kumar S, Reddy MC, Kaer LV, Moodley P, et al. Simultaneous inhibition of T helper 2 and T regulatory cell differentiation by small molecules enhances Bacillus Calmette-Guerin vaccine efficacy against tuberculosis. J Biol Chem (2014) 289(48):33404-11. doi:10.1074/jbc. M114.600452
172. Pitt JM, Stavropoulos E, Redford PS, Beebe AM, Bancroft GJ, Young DB, et al. Blockade of IL-10 signaling during Bacillus Calmette-Guerin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-gamma and IL-17 responses and increases protection to Mycobacterium tuberculosis infection. J Immunol (2012) 189:4079-87. doi:10.4049/jimmunol.1201061
173. Dhiman R, Periasamy S, Barnes PF, Jaiswal AG, Paidipally P, Barnes AB, et al. NK1.1+ cells and IL-22 regulate vaccine-induced protective immunity against challenge with Mycobacterium tuberculosis. J Immunol (2012) 189:897-905. doi:10.4049/jimmunol.1102833
174. Jaron B, Maranghi E, Leclerc C, Majlessi L. Effect of attenuation of Treg during BCG immunization on anti-mycobacterial Th1 responses and protection against Mycobacterium tuberculosis. PLoS One (2008) 3:e2833. doi:10.1371/journal.pone.0002833
175. Berod L, Stuve P, Varela F, Behrends J, Swallow M, Kruse F, et al. Rapid rebound of the Treg compartment in DEREG mice limits the impact of Treg depletion on mycobacterial burden, but prevents autoimmunity. PLoS One (2014) 9:e102804. doi:10.1371/journal.pone.0102804
176. Bayry J, Tchilian EZ, Davies MN, Forbes EK, Draper SJ, Kaveri SV, et al. In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination. Proc Natl Acad Sci U S A (2008) 105:10221-6. doi:10.1073/pnas.0803453105
177. Mills KH. Designer adjuvants for enhancing the efficacy of infectious disease and cancer vaccines based on suppression of regulatory T cell induction. Immunol Lett (2009) 122:108-11. doi:10.1016/j.imlet.2008.11.007